Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial

JAMA ◽  
1991 ◽  
Vol 266 (1) ◽  
pp. 84-88 ◽  
Author(s):  
A. M. Levine
2013 ◽  
Vol 123 (11) ◽  
pp. 589-595 ◽  
Author(s):  
Katarzyna Krawczyk ◽  
Wojciech Jurczak ◽  
Monika Długosz‑Danecka ◽  
Agnieszka Zauska‑Giza ◽  
Justyna Dzietczenia ◽  
...  

2019 ◽  
Vol 202 (12) ◽  
pp. 3412-3422 ◽  
Author(s):  
Susanta Mondal ◽  
Suresh B. Rangasamy ◽  
Avik Roy ◽  
Sridevi Dasarathy ◽  
Jeffrey H. Kordower ◽  
...  

2003 ◽  
Vol 20 (3) ◽  
pp. 187-200
Author(s):  
Peter Johan Moe ◽  
Are Holen ◽  
Randi Nygaard ◽  
Anders Glomstein ◽  
Birgit Madsen ◽  
...  

2007 ◽  
Vol 86 (6) ◽  
pp. 356-360 ◽  
Author(s):  
Steven M. Feinberg ◽  
S.H. Ignatius Ou ◽  
Mai Gu ◽  
Terry Y. Shibuya

Burkitt's lymphoma is a highly aggressive, mature B cell non-Hodgkin's lymphoma that is rare outside Africa. We report a case of Burkitt's lymphoma presenting as a rapidly expanding tongue-base mass that caused airway obstruction in an 80-year-old Palestinian man living in California. According to our review of the literature, this is only the third reported case of Burkitt's lymphoma arising in the base of the tongue. We also discuss the incidence, epidemiology, genetics, prognosis, and treatment of this malignancy. Because Burkitt's lymphoma is one of the fastest-growing tumors in humans, rapid diagnosis and treatment are important. Treatment involves brief-duration, high-intensity chemotherapy and central nervous system prophylaxis. It is important for the otolaryngologist to recognize this disease and to understand the steps necessary to treat this aggressive tumor.


Sign in / Sign up

Export Citation Format

Share Document